Venlafaxine Hydrochloride
Product Images NDC 53002-2361

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 53002-2361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530022361)

Venlafaxine Hydrochloride 150 mg ER capsules label from RPK Pharmaceuticals, Inc., showing a package of 30 capsules. The label includes dosage instructions to take one capsule daily or as directed and features barcodes, lot number, expiration date, and placeholders for patient and prescriber information.*

FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

A pharmacokinetic interaction chart showing the effect of various interacting drugs on venlafaxine exposure. The horizontal axis represents change relative to a reference value for Cmax, AUC, and ODV parameters. Recommendations for concomitant use or dose adjustments are listed, including instructions such as 'avoid concomitant use', 'no dose adjustment', and 'use with caution' for several interacting drugs like ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium.*

FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

A pharmacokinetic fold change chart showing the interaction between Venlafaxine Hydrochloride and various drugs (e.g., ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, lithium). It plots Cmax and AUC changes relative to reference values with 90% confidence intervals, along with dosage recommendations or clinical significance notes.*

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

A forest plot chart showing the fold change with 90% confidence intervals in pharmacokinetic parameters (Cmax, AUC) of venlafaxine in special populations including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60 years, and gender differences. Dose adjustment recommendations are provided based on these changes.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride, showing its molecular arrangement with a cyclohexanol group, dimethylaminoethyl side chain, methoxy-substituted aromatic ring, and associated hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.